<DOC>
	<DOCNO>NCT00187915</DOCNO>
	<brief_summary>This study prospective interventional trial de novo renal transplant recipient , aim validate strategy combine use early post transplant MPA AUC sampling , subsequent MPA trough level monitoring implement MPA PK monitor clinically applicable fashion .</brief_summary>
	<brief_title>Pilot Trial Implementation MPA PK Monitoring Strategy</brief_title>
	<detailed_description>Mycophenolate mofetil MMF ( CellCeptÂ® Roche ) mofetil ester mycophenolic acid ( MPA ) , active immunosuppressant . MMF significantly decrease episode acute rejection kidney transplant patient ; medication without adequate pharmacokinetic drug monitoring , issue immunosuppression arises . For reason , big challenge lie establish feasible mean MPA pharmacokinetic monitoring . Thus far study show measure MPA trough level alone correlate rejection , unlike MPA Area Under concentration time Curve ( AUC ) , due large incidence inter- intra-patient variability . This first prospective blind trial set analyze correlation individualize MPA AUC trough level kidney transplant patient hop establish efficacious way monitoring MPA . MPA target trough level correspond AUC great 30 mg x h/L could utilize maintenance measurement .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>primary secondary cadaveric live donor kidney recipient On Cellcept Multi organ recipient Documented noncompliance Not calcineurin inhibitor GFR &lt; 25 ml/min Cockcroft Gault equation Serum albumin &lt; 2.5 mg/dl Pregnant Active serious digestive disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Renal transplant</keyword>
	<keyword>Cellcept</keyword>
	<keyword>Therapeutic drug level</keyword>
	<keyword>Mycophenolate mofetil ( MMF )</keyword>
	<keyword>Mycophenolate Acid ( MPA )</keyword>
	<keyword>Oral Bioavailability</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>